Borden EC - Search Results

1

Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.

Carlin JM, Borden EC, Sondel PM, Byrne GI. Carlin JM, et al. Among authors: borden ec. J Immunol. 1987 Oct 1;139(7):2414-8. J Immunol. 1987. PMID: 2443564

2

Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.

Schiller JH, Horisberger MA, Bittner G, Carlin JM, Storer B, Byrne GI, Willson JK, Borden EC. Schiller JH, et al. Among authors: borden ec. J Biol Response Mod. 1990 Aug;9(4):368-77. J Biol Response Mod. 1990. PMID: 2395002

3

Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.

Carlin JM, Borden EC, Sondel PM, Byrne GI. Carlin JM, et al. Among authors: borden ec. J Leukoc Biol. 1989 Jan;45(1):29-34. doi: 10.1002/jlb.45.1.29. J Leukoc Biol. 1989. PMID: 2463322

4

Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects.

Carlin JM, Ozaki Y, Byrne GI, Brown RR, Borden EC. Carlin JM, et al. Among authors: borden ec. Experientia. 1989 Jun 15;45(6):535-41. doi: 10.1007/BF01990503. Experientia. 1989. PMID: 2472288 Review.

5

Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages.

Carlin JM, Borden EC, Byrne GI. Carlin JM, et al. Among authors: borden ec. J Interferon Res. 1989 Jun;9(3):329-37. doi: 10.1089/jir.1989.9.329. J Interferon Res. 1989. PMID: 2501398

6

Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages.

Schmitz JL, Carlin JM, Borden EC, Byrne GI. Schmitz JL, et al. Among authors: borden ec. Infect Immun. 1989 Oct;57(10):3254-6. doi: 10.1128/iai.57.10.3254-3256.1989. Infect Immun. 1989. PMID: 2506136 Free PMC article.

7

Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser.

Carlin JM, Borden EC, Byrne GI. Carlin JM, et al. Among authors: borden ec. J Interferon Res. 1989 Apr;9(2):167-73. doi: 10.1089/jir.1989.9.167. J Interferon Res. 1989. PMID: 2785576

8

Lymphokines and cytokines as cancer treatment. Immunotherapy realized.

Borden EC, Sondel PM. Borden EC, et al. Cancer. 1990 Feb 1;65(3 Suppl):800-14. doi: 10.1002/1097-0142(19900201)65:3+<800::aid-cncr2820651328>3.0.co;2-y. Cancer. 1990. PMID: 2406003 Review.

9

Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.

Meyer KC, Cornwell R, Carlin JM, Powers C, Irizarry A, Byrne GI, Borden EC. Meyer KC, et al. Among authors: borden ec. Am J Respir Cell Mol Biol. 1992 Jun;6(6):639-46. doi: 10.1165/ajrcmb/6.6.639. Am J Respir Cell Mol Biol. 1992. PMID: 1591013

10

Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.

Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG. Brown RR, et al. Among authors: borden ec. Adv Exp Med Biol. 1991;294:425-35. doi: 10.1007/978-1-4684-5952-4_39. Adv Exp Med Biol. 1991. PMID: 1722946 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters